1. Home
  2. IMRN vs INBS Comparison

IMRN vs INBS Comparison

Compare IMRN & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$0.79

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$3.90

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMRN
INBS
Founded
1994
2016
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8M
6.4M
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
IMRN
INBS
Price
$0.79
$3.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.4K
78.1K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
68.65
EPS
N/A
N/A
Revenue
N/A
$1,980,484.00
Revenue This Year
N/A
$778.48
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.54
52 Week High
$2.38
$24.90

Technical Indicators

Market Signals
Indicator
IMRN
INBS
Relative Strength Index (RSI) 43.15 32.99
Support Level $0.69 $1.49
Resistance Level $1.96 $7.25
Average True Range (ATR) 0.07 0.36
MACD 0.00 0.13
Stochastic Oscillator 22.79 8.33

Price Performance

Historical Comparison
IMRN
INBS

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Share on Social Networks: